Aptus Pharma
Aptus Pharma (APPL) share price was ₹462.70 at the 28 Oct 2026 close; market capitalisation ₹794 Cr; sector Consumer Goods. The share price rose 777.0% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹32.2 Cr, against ₹14.8 Cr a year earlier and net profit rose 60.3% year on year to ₹2.87 Cr (compared with Mar 2025). Promoters held 72.89% of Aptus Pharma in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 54/100 (Average) as of 28 Oct 2026.
Key Fundamentals
SMEConsumer DurablesConsumer DiscretionaryPrice-based figures as of 28 Oct 2026, 15:30 IST · TTM
Peer Comparison
Healthcare › Consumer Goods › Household Appliances › Pharmaceuticals
| ₹1,766.10 | 35.03 | 4,23,747 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,626.00 | 87.37 | 2,55,540 Cr | 15.25 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,595.70 | 72.15 | 1,74,806 Cr | 9.51 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,183.70 | 107.89 | 1,17,988 Cr | 22.26 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,180.40 | 26.27 | 1,17,745 Cr | 4.34 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,340.70 | 34.72 | 1,11,906 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,370.70 | 32.84 | 1,10,733 Cr | 3.13 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Aptus Pharma (this company) | — | — | 794 Cr | 34.00 | 0.00% | 19.79% | 29.60% | — | — |
| Median 8 companies | ₹1,766.10 | 35.03 | 1,17,867 Cr | 7.29 | 0.47% | 14.56% | 18.45% | 28,515 Cr | 3,184 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 81/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 40.8%
Weaknesses
4- Stock is trading at 34.8 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 99.8 to 147 days.
- Working capital days have increased from 73.4 days to 117 days
Technical Indicators
Oscillators
Bullish
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 13.98% · Mar 2026
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 9.76 | 14.8 | 14.38 | 32.2 |
| Expenses | 7.78 | 11.93 | 11.45 | 27.7 |
| Operating Profit | 1.98 | 2.87 | 2.93 | 4.5 |
| OPM % | 20.29% | 19.39% | 20.38% | 13.98% |
| Other Income | 0 | 0.08 | 0.01 | 0.12 |
| Interest | 0.11 | 0.36 | 0.43 | 0.35 |
| Depreciation | 0.11 | 0.15 | 0.16 | 0.25 |
| PBT | 1.76 | 2.44 | 2.35 | 4.02 |
| Tax % | 25.57% | 26.23% | 25.53% | 28.61% |
| Net Profit | 1.31 | 1.79 | 1.75 | 2.87 |
| EPS (₹) | 1.05 | 1.43 | 1.02 | 1.67 |
Profit & Loss
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 13.9 | 17.81 | 24.56 | 46.56 |
| Expenses | 13.28 | 16.27 | 19.71 | 39.11 |
| Operating Profit | 0.62 | 1.54 | 4.85 | 7.45 |
| OPM % | 4.46% | 8.65% | 19.75% | 16% |
| Other Income | 0 | 0.03 | 0.08 | 0.13 |
| Interest | 0.14 | 0.24 | 0.47 | 0.8 |
| Depreciation | 0.18 | 0.21 | 0.27 | 0.41 |
| PBT | 0.3 | 1.12 | 4.19 | 6.37 |
| Tax % | 33.33% | 28.57% | 26.01% | 27.47% |
| Net Profit | 0.19 | 0.8 | 3.1 | 4.62 |
| EPS (₹) | 0.48 | 2 | 2.48 | 2.69 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 0.3 | 0.3 | 5 | 6.86 |
| Reserves | 0.67 | 1.47 | 1.97 | 16.49 |
| Borrowings | 2.22 | 5.31 | 10.36 | 7.18 |
| Other Liabilities | 3.02 | 2.95 | 4.59 | 13.01 |
| Total Liabilities | 6.21 | 10.03 | 21.92 | 43.54 |
| Fixed Assets | 0.52 | 0.63 | 0.99 | 2.77 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 5.69 | 9.4 | 20.93 | 40.77 |
| Total Assets | 6.21 | 10.03 | 21.92 | 43.54 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | -0.18 | -2.17 | -1.84 | -5.6 |
| Investing | -0.35 | -0.3 | -0.54 | -6.37 |
| Financing | 0.81 | 2.86 | 6.68 | 7.79 |
| Net Cash Flow | 0.28 | 0.38 | 4.3 | -4.19 |
| Free Cash Flow | -0.53 | -2.5 | -2.46 | -7.79 |
| CFO/EBITDA | -10 | -119 | -15 | -59 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 63.02 | 68.66 | 83.82 | 147 |
| Inventory Days | 176 | 184 | 285 | 232 |
| Days Payable | 104 | 72.25 | 52.89 | 139 |
| Cash Conversion Cycle | 135 | 180 | 316 | 239 |
| Working Capital Days | 51.99 | 67.02 | 36.41 | 117 |
| ROCE % | — | 26.48% | 38.18% | 29.96% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aptus Pharma insights
63 extracted metrics + investor summaries across FY21–FY26.
Documents
Frequently Asked Questions about Aptus Pharma
What does Aptus Pharma Ltd do?
Where is Aptus Pharma Ltd (APPL) listed?
Which sector does Aptus Pharma Ltd belong to?
What is the market capitalisation of Aptus Pharma Ltd?
What is the 52-week high and low of Aptus Pharma Ltd?
What is the Return on Equity (ROE) of Aptus Pharma Ltd?
Company Information
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544529.md for Aptus Pharma Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.